Rituximab leukoencephalopathy

Rituximab CD20 Non-Hodgkins lymphoma Fever, infusion reactions, tumor lysis syndrome, infections, progressive multifocal leukoencephalopathy (PML)... [Pg.455]

Rituximab (Rituxan/ MabThera) CD20 1997 Not conducted No information 2-month monkey B-cell depletion Tumor lysis syndrome (TLS), progressive multifocal leukoencephalopathy (PML), hepatitis B, infections, cardiac arrhythmias and angina, bowel obstruction and perforation, cytopenias... [Pg.419]

Nervous system Rituximab can be associated with an increased risk of progressive multifocal leukoencephalopathy [294, 295 ]. [Pg.792]

Fleischmann RM. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis. Arthritis Rheum 2009 60 3225-8. [Pg.812]